Day Two at ACHEMA - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Day Two at ACHEMA



Another day and I’ve seen many more technologies here in Frankfurt at ACHEMA.

AVEVA have unveiled a new plant design technology. The software should offer faster deployment and an intuitive graphic user interface (GUI) with mobile access. It offers richer design capabilities that will improve automation and visibility. The company also claim that it will be faster and 20% more efficient than their previous, tried and tested product.

BOSCH had a vast array of products on show. Their Fast Air Lock ISS 1000 allows for the contamination-free transfer of pharmaceutical equipment. It is the 100th isolator sold to the pharmaceutical trade. They also have a unit based on soft x-ray technology for the inspection of filled hard capsules. Their Marvus system consists of a headset with a camera, display, earphones and microphone. This is all for remote service from BOSCH experts. This product is also up for an innovation award.

Other innovations I noted were ATMI’s large array of mixers and bioreactors for single-use technology. Conductive levitation is a unique mixing technology and there is no contact. Meanwhile. Thermo Scientific had a freezer on show that will text you if it starts defrosting. They have also developed an extruder for hot-melt extrusion, in association with BASF.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
USP Faces New Challenges

Click here